NASH on the cusp: an emerging market opportunity
PharmaLive,
Published: Oct 23, 2023 By Heather McKenzie BioSpace Once a hot target for investors, the non-alcoholic steatohepatitis space…
Published: Oct 23, 2023 By Heather McKenzie BioSpace Once a hot target for investors, the non-alcoholic steatohepatitis space…
Pictured: Liver tissue under a microscope/iStock, Sinhyu Once a hot target for investors, the non-alcoholic steatohepatitis…
Steatohepatitis is a condition in which fatty build-ups in the liver cause inflammation and liver damage.